Operating margin moved 316 bp lower
Operating margin changed -316 basis points from the comparable as-filed period. This reverses 3 consecutive comparable moves in the opposite direction.
-44.96%→-48.12%3 prior comparisons
GROSSPATTERN / DETERMINISTIC EVIDENCE / V3
Search securities →TELA financial changes
Ranked by interpretable importance, issuer history, magnitude, and accounting profile. No directional recommendation.
Gross margin moved 244 bp higher
Gross margin changed +244 basis points from the comparable as-filed period.
69.84%→72.28%3 prior comparisons
Stock-based compensation decreased 37.8%
Stock-based compensation changed -37.8% from the comparable as-filed period.
$985,000→$613,0003 prior comparisons
Net income decreased 13.5%
Net income changed -13.5% from the comparable as-filed period.
-$9.9M→-$11.3M3 prior comparisons
Revenue decreased 4.5%
Revenue changed -4.5% from the comparable as-filed period. This reverses 3 consecutive comparable moves in the opposite direction.
$20.2M→$19.3M3 prior comparisons
Research & development increased 23.6%
Research & development changed +23.6% from the comparable as-filed period.
$2.2M→$2.7M3 prior comparisons
Inventory / revenue moved 103 bp higher
Inventory / revenue changed +103 basis points from the comparable as-filed period. This reverses 3 consecutive comparable moves in the opposite direction.
56.30%→57.33%3 prior comparisons
Cash & equivalents decreased 13.0%
Cash & equivalents changed -13.0% from the comparable as-filed period.
$35.0M→$30.4M2 prior comparisons
SBC / revenue moved 170 bp lower
SBC / revenue changed -170 basis points from the comparable as-filed period.
4.88%→3.18%3 prior comparisons
Operating income decreased 2.2%
Operating income changed -2.2% from the comparable as-filed period.
-$9.1M→-$9.3M3 prior comparisons
Inventory decreased 2.7%
Inventory changed -2.7% from the comparable as-filed period. The change ranks at the 0th percentile of 4 prior comparable changes.
$11.4M→$11.1M4 prior comparisons
Gross profit decreased 1.1%
Gross profit changed -1.1% from the comparable as-filed period. This reverses 3 consecutive comparable moves in the opposite direction.
$14.1M→$13.9M3 prior comparisons
Method Importance combines metric-family relevance, magnitude, issuer-history unusualness, persistence, and financial-statement significance. It is analytical prioritization, not a legal materiality conclusion or investment signal.